Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
Science (New York, N.Y.)
|
January 5, 1990
Identification of a chromosome 18q gene that is altered in colorectal cancers
E R Fearon, K R Cho, J M Nigro, et al.
Journal of the National Cancer Institute
|
February 22, 2001
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis
R Bos, H Zhong, C F Hanrahan, et al.
Cancer Research
|
October 19, 2001
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
T L DeWeese, H van der Poel, S Li, et al.
Cancer Research
|
April 15, 1997
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer
J W Simons, E M Jaffee, C E Weber, et al.
Cancer Research
|
October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
J W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
W G Nelson, J W Simons, B Mikhak, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
Science (New York, N.Y.)
|
January 5, 1990
Identification of a chromosome 18q gene that is altered in colorectal cancers
E R Fearon, K R Cho, J M Nigro, et al.
Journal of the National Cancer Institute
|
February 22, 2001
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis
R Bos, H Zhong, C F Hanrahan, et al.
Cancer Research
|
October 19, 2001
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
T L DeWeese, H van der Poel, S Li, et al.
Cancer Research
|
April 15, 1997
Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer
J W Simons, E M Jaffee, C E Weber, et al.
Cancer Research
|
October 28, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
J W Simons, B Mikhak, J F Chang, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2000
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
W G Nelson, J W Simons, B Mikhak, et al.
Page
of 14